Ara
Toplam kayıt 8, listelenen: 1-8
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
(Turkiye Klinikleri, 2021)
Background/aim: To evaluate treatment adherence and predictors of drug discontinuation among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after the announcement of the COVID-19 pandemic. ...
UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS
(Bmj Publishing Group, 2019)
[No Abstract Available]
Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry
(Aves, 2020)
Objective: Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology. Methods: Within the PsA international ...
Methodology of a new inflammatory arthritis registry: TReasure
(Tubitak Scientific & Technical Research Council Turkey, 2018)
Background/aim: The TReasure registry, created in 2017, is an observational multicenter cohort that includes inflammatory arthritis patients. This article reviews the methodology and objectives of the TReasure registry ...
Smoking May Be Related to Sacroiliitis in Enteropathic Arthritis Patients: Treasure Real-Life Preliminary Data
(Bmj Publishing Group, 2019)
[No Abstract Available]
Biosimilar Infliximab Experience in Spondyloartritis Patients: Treasure Real Life Results
(Bmj Publishing Group, 2020)
[No Abstract Available]
Treatment Satisfaction, Expectations, Patient Preferences, and Characteristics in Patients with Rheumatoid Arthritis (Ra): Turkish Cohort Results of the Sense Study
(Bmj Publishing Group, 2021)
[No Abstract Available]
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
(Springer Heidelberg, 2022)
This study aimed to compare Tuberculin Skin Test (TST) and QuantiFERON (R)-TB Gold In-Tube (QFT-GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients scheduled for biological and targeted synthetic ...